melanoma: be more deadly than women

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents cancer
Weight: 0.71
, skin cancer
Weight: 0.70
, tumor
Weight: 0.63
, cancer cell
Weight: 0.61
, condition
Weight: 0.59
Siblings lung cancer
Weight: 0.40
, lymphoma
Weight: 0.38
, prostate cancer
Weight: 0.38
, liver cancer
Weight: 0.38
, breast cancer
Weight: 0.37

Related properties

Property Similarity
be more deadly than women 1.00
be more deadly for men 0.96
is deadly 0.86
be more common in females 0.79
have higher in men 0.78
be more common in males 0.77
is most dangerous 0.77
is fatal 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.44
Rule weight: 0.66
Evidence weight: 0.88
Similarity weight: 0.76
Evidence: 0.81
Plausible(skin cancer, is fatal)
Evidence: 0.63
¬ Typical(melanoma, be more deadly than women)
0.43
Rule weight: 0.66
Evidence weight: 0.75
Similarity weight: 0.86
Evidence: 0.60
Plausible(skin cancer, is deadly)
Evidence: 0.63
¬ Typical(melanoma, be more deadly than women)
0.41
Rule weight: 0.66
Evidence weight: 0.71
Similarity weight: 0.86
Evidence: 0.54
Plausible(cancer, is deadly)
Evidence: 0.63
¬ Typical(melanoma, be more deadly than women)
0.40
Rule weight: 0.66
Evidence weight: 0.79
Similarity weight: 0.76
Evidence: 0.66
Plausible(cancer, is fatal)
Evidence: 0.63
¬ Typical(melanoma, be more deadly than women)

Plausibility inheritance from parent to child

0.05
Rule weight: 0.09
Evidence weight: 0.66
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.54
¬ Plausible(cancer, is deadly)
0.05
Rule weight: 0.09
Evidence weight: 0.62
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.60
¬ Plausible(skin cancer, is deadly)
0.04
Rule weight: 0.09
Evidence weight: 0.58
Similarity weight: 0.76
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.66
¬ Plausible(cancer, is fatal)
0.03
Rule weight: 0.09
Evidence weight: 0.49
Similarity weight: 0.76
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.81
¬ Plausible(skin cancer, is fatal)

Remarkability exclusitivity betweem a parent and a child

0.42
Rule weight: 0.58
Evidence weight: 0.85
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.79
¬ Remarkable(skin cancer, is deadly)
0.42
Rule weight: 0.58
Evidence weight: 0.84
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.85
¬ Remarkable(cancer, is deadly)
0.38
Rule weight: 0.58
Evidence weight: 0.86
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.73
¬ Remarkable(skin cancer, is fatal)
0.36
Rule weight: 0.58
Evidence weight: 0.84
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.87
¬ Remarkable(cancer, is fatal)

Remarkability exclusitivity between siblings

0.10
Rule weight: 0.13
Evidence weight: 0.85
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.81
¬ Remarkable(lymphoma, is deadly)
0.10
Rule weight: 0.13
Evidence weight: 0.84
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.83
¬ Remarkable(prostate cancer, is deadly)
0.10
Rule weight: 0.13
Evidence weight: 0.84
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.84
¬ Remarkable(liver cancer, is deadly)
0.10
Rule weight: 0.13
Evidence weight: 0.84
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.84
¬ Remarkable(lung cancer, is deadly)
0.10
Rule weight: 0.13
Evidence weight: 0.84
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.85
¬ Remarkable(breast cancer, is deadly)
0.09
Rule weight: 0.13
Evidence weight: 0.88
Similarity weight: 0.79
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.63
¬ Remarkable(breast cancer, be more common in females)
0.09
Rule weight: 0.13
Evidence weight: 0.89
Similarity weight: 0.77
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.56
¬ Remarkable(lung cancer, be more common in males)
0.09
Rule weight: 0.13
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.69
¬ Remarkable(lymphoma, is fatal)
0.09
Rule weight: 0.13
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.79
¬ Remarkable(breast cancer, is fatal)
0.09
Rule weight: 0.13
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.79
¬ Remarkable(lung cancer, is fatal)
0.09
Rule weight: 0.13
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.81
¬ Remarkable(liver cancer, is fatal)

Remarkability from parent implausibility

0.32
Rule weight: 0.42
Evidence weight: 0.88
Similarity weight: 0.86
Evidence: 0.60
Plausible(skin cancer, is deadly)
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.36
¬ Plausible(melanoma, be more deadly than women)
0.31
Rule weight: 0.42
Evidence weight: 0.86
Similarity weight: 0.86
Evidence: 0.54
Plausible(cancer, is deadly)
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.36
¬ Plausible(melanoma, be more deadly than women)
0.30
Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.81
Plausible(skin cancer, is fatal)
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.36
¬ Plausible(melanoma, be more deadly than women)
0.29
Rule weight: 0.42
Evidence weight: 0.90
Similarity weight: 0.76
Evidence: 0.66
Plausible(cancer, is fatal)
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.36
¬ Plausible(melanoma, be more deadly than women)

Remarkability from sibling implausibility

0.49
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.85
Remarkable(breast cancer, is deadly)
Evidence: 0.46
¬ Plausible(breast cancer, is deadly)
0.49
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.84
Remarkable(liver cancer, is deadly)
Evidence: 0.44
¬ Plausible(liver cancer, is deadly)
0.49
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.83
Remarkable(prostate cancer, is deadly)
Evidence: 0.45
¬ Plausible(prostate cancer, is deadly)
0.49
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.84
Remarkable(lung cancer, is deadly)
Evidence: 0.53
¬ Plausible(lung cancer, is deadly)
0.48
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.81
Remarkable(lymphoma, is deadly)
Evidence: 0.59
¬ Plausible(lymphoma, is deadly)
0.42
Rule weight: 0.60
Evidence weight: 0.92
Similarity weight: 0.76
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.81
Remarkable(liver cancer, is fatal)
Evidence: 0.66
¬ Plausible(liver cancer, is fatal)
0.41
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.76
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.79
Remarkable(breast cancer, is fatal)
Evidence: 0.71
¬ Plausible(breast cancer, is fatal)
0.41
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.76
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.79
Remarkable(lung cancer, is fatal)
Evidence: 0.71
¬ Plausible(lung cancer, is fatal)
0.40
Rule weight: 0.60
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.63
Remarkable(breast cancer, be more common in females)
Evidence: 0.67
¬ Plausible(breast cancer, be more common in females)
0.38
Rule weight: 0.60
Evidence weight: 0.84
Similarity weight: 0.76
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.69
Remarkable(lymphoma, is fatal)
Evidence: 0.82
¬ Plausible(lymphoma, is fatal)
0.38
Rule weight: 0.60
Evidence weight: 0.82
Similarity weight: 0.77
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.56
Remarkable(lung cancer, be more common in males)
Evidence: 0.65
¬ Plausible(lung cancer, be more common in males)

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.25
¬ Salient(melanoma, be more deadly than women)

Similarity expansion

0.77
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.96
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.10
¬ Plausible(melanoma, be more deadly for men)
0.77
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.96
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.08
¬ Remarkable(melanoma, be more deadly for men)
0.76
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.96
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.10
¬ Salient(melanoma, be more deadly for men)
0.71
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.96
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.38
¬ Typical(melanoma, be more deadly for men)
0.58
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.17
¬ Remarkable(melanoma, be more common in females)
0.56
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.79
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.23
¬ Salient(melanoma, be more common in females)
0.55
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.77
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.20
¬ Remarkable(melanoma, be more common in males)
0.54
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.78
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.23
¬ Remarkable(melanoma, have higher in men)
0.53
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.79
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.33
¬ Plausible(melanoma, be more common in females)
0.53
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.78
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.27
¬ Salient(melanoma, have higher in men)
0.53
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.79
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.60
¬ Typical(melanoma, be more common in females)
0.53
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.78
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.58
¬ Typical(melanoma, have higher in men)
0.52
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.77
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.28
¬ Salient(melanoma, be more common in males)
0.51
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.78
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.36
¬ Plausible(melanoma, have higher in men)
0.50
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.86
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.87
¬ Typical(melanoma, is deadly)
0.49
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.77
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.67
¬ Typical(melanoma, be more common in males)
0.49
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.77
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.41
¬ Plausible(melanoma, be more common in males)
0.44
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.77
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.40
¬ Remarkable(melanoma, is most dangerous)
0.44
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.77
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.90
¬ Typical(melanoma, is most dangerous)
0.42
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.96
¬ Typical(melanoma, is fatal)
0.39
Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.86
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.58
¬ Remarkable(melanoma, is deadly)
0.36
Rule weight: 0.85
Evidence weight: 0.49
Similarity weight: 0.86
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.81
¬ Plausible(melanoma, is deadly)
0.35
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.76
Evidence: 0.19
Remarkable(melanoma, be more deadly than women)
Evidence: 0.56
¬ Remarkable(melanoma, is fatal)
0.33
Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.77
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.77
¬ Plausible(melanoma, is most dangerous)
0.28
Rule weight: 0.85
Evidence weight: 0.43
Similarity weight: 0.77
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.76
¬ Salient(melanoma, is most dangerous)
0.27
Rule weight: 0.85
Evidence weight: 0.42
Similarity weight: 0.76
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.91
¬ Plausible(melanoma, is fatal)
0.26
Rule weight: 0.85
Evidence weight: 0.35
Similarity weight: 0.86
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.87
¬ Salient(melanoma, is deadly)
0.19
Rule weight: 0.85
Evidence weight: 0.29
Similarity weight: 0.76
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.95
¬ Salient(melanoma, is fatal)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.25
Salient(melanoma, be more deadly than women)
Evidence: 0.63
¬ Typical(melanoma, be more deadly than women)
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)

Typical implies Plausible

0.29
Rule weight: 0.48
Evidence weight: 0.60
Similarity weight: 1.00
Evidence: 0.36
Plausible(melanoma, be more deadly than women)
Evidence: 0.63
¬ Typical(melanoma, be more deadly than women)

Typicality and Rermarkability incompatibility between a parent and a child

0.40
Rule weight: 0.51
Evidence weight: 0.91
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.48
¬ Typical(cancer, is deadly)
0.39
Rule weight: 0.51
Evidence weight: 0.89
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.56
¬ Typical(skin cancer, is deadly)
0.34
Rule weight: 0.51
Evidence weight: 0.89
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.59
¬ Typical(cancer, is fatal)
0.33
Rule weight: 0.51
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.82
¬ Typical(skin cancer, is fatal)

Typicality and Rermarkability incompatibility between siblings

0.11
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.33
¬ Typical(liver cancer, is deadly)
0.11
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.35
¬ Typical(breast cancer, is deadly)
0.11
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.35
¬ Typical(prostate cancer, is deadly)
0.11
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.44
¬ Typical(lung cancer, is deadly)
0.11
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 0.86
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.53
¬ Typical(lymphoma, is deadly)
0.09
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.72
¬ Typical(breast cancer, be more common in females)
0.09
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.61
¬ Typical(liver cancer, is fatal)
0.09
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.72
¬ Typical(lung cancer, be more common in males)
0.09
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.68
¬ Typical(breast cancer, is fatal)
0.09
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.68
¬ Typical(lung cancer, is fatal)
0.09
Rule weight: 0.14
Evidence weight: 0.84
Similarity weight: 0.76
Evidence: 0.19
¬ Remarkable(melanoma, be more deadly than women)
Evidence: 0.84
¬ Typical(lymphoma, is fatal)

Typicality inheritance from parent to child

0.34
Rule weight: 0.48
Evidence weight: 0.82
Similarity weight: 0.86
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.48
¬ Typical(cancer, is deadly)
0.33
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 0.86
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.56
¬ Typical(skin cancer, is deadly)
0.29
Rule weight: 0.48
Evidence weight: 0.78
Similarity weight: 0.76
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.59
¬ Typical(cancer, is fatal)
0.26
Rule weight: 0.48
Evidence weight: 0.70
Similarity weight: 0.76
Evidence: 0.63
Typical(melanoma, be more deadly than women)
Evidence: 0.82
¬ Typical(skin cancer, is fatal)